Daniel J. Brennan, EVP and CFO at BOSTON SCIENTIFIC CORP (BSX), sold 46,588 shares at $105.07 ($4.9M) on 2025-02-12, disclosed to the SEC on 2025-02-13.
Scheduled sale ($4.9M) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.98 | 16,414 | $1.7M | 35.4% |
| 2 | $105.07 | 15,087 | $1.6M | 32.3% |
| 3 | $105.07 | 15,087 | $1.6M | 32.3% |
| Total | $105.39 avg | 46,588 | $4.9M | 100% |
| Filing → |
| BSX | SELL | 2024-05-23 | $16.9M | — | Filing → |
| BSX | SELL | 2024-02-20 | $1.8M | — | Filing → |
| BSX | SELL | 2023-03-02 | $8.5M | — | Filing → |